TY - JOUR AU - Chan, J. K. AU - Tian, C. AU - Teoh, D. AU - Monk, B. J. AU - Herzog, T. AU - Kapp, D. S. AU - Bell, J. PY - 2010 DA - 2010// TI - Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study JO - Gynecol Oncol VL - 116 UR - https://doi.org/10.1016/j.ygyno.2009.10.074 DO - 10.1016/j.ygyno.2009.10.074 ID - Chan2010 ER - TY - JOUR PY - 2011 DA - 2011// TI - Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogene JO - Pathology VL - 43 UR - https://doi.org/10.1097/PAT.0b013e328348a6e7 DO - 10.1097/PAT.0b013e328348a6e7 ID - ref2 ER - TY - JOUR AU - Kurman, R. J. AU - Shi, I. -. M. PY - 2010 DA - 2010// TI - The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory JO - Am J Surg Pathol VL - 34 UR - https://doi.org/10.1097/PAS.0b013e3181cf3d79 DO - 10.1097/PAS.0b013e3181cf3d79 ID - Kurman2010 ER - TY - JOUR AU - Zannoni, G. F. AU - Morassi, F. AU - Prisco, M. G. AU - De Stefano, I. AU - Vellone, V. G. AU - Arena, V. AU - Scambia, G. AU - Gallo, D. PY - 2012 DA - 2012// TI - Clinicopathologic and immunohistochemical features of ovarian clear cell carcinomas in comparison with type I and type II tumors JO - IntJ Gynecol Pathol VL - 31 UR - https://doi.org/10.1097/PGP.0b013e3182518557 DO - 10.1097/PGP.0b013e3182518557 ID - Zannoni2012 ER - TY - JOUR AU - Zhao, C. AU - Wu, L. AU - Barner, R. PY - 2011 DA - 2011// TI - Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support Two related pathways of tumor development JO - J Cancer Educ VL - 2 UR - https://doi.org/10.7150/jca.2.94 DO - 10.7150/jca.2.94 ID - Zhao2011 ER - TY - JOUR AU - Chan, J. K. AU - Teoh, D. AU - Hu, J. M. AU - Shin, J. Y. AU - Osann, K. AU - Kapp, D. S. PY - 2008 DA - 2008// TI - Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers JO - Gynecol Oncol VL - 109 UR - https://doi.org/10.1016/j.ygyno.2008.02.006 DO - 10.1016/j.ygyno.2008.02.006 ID - Chan2008 ER - TY - JOUR AU - Anglesio, M. S. AU - Carey, M. S. AU - Kobel, M. AU - Mackay, H. AU - Huntsman, D. G. PY - 2011 DA - 2011// TI - Clear cell carcinoma of the ovary: a report from the first ovarian clear cell symposium, June 24th, 2010 JO - Gynecol Oncol VL - 121 UR - https://doi.org/10.1016/j.ygyno.2011.01.005 DO - 10.1016/j.ygyno.2011.01.005 ID - Anglesio2011 ER - TY - JOUR AU - Köbel, M. AU - Kalloger, S. E. AU - Santos, J. L. AU - Huntsman, D. G. AU - Gilks, C. B. AU - Swenerton, K. D. PY - 2010 DA - 2010// TI - Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications JO - Gynecol Oncol VL - 116 UR - https://doi.org/10.1016/j.ygyno.2009.09.029 DO - 10.1016/j.ygyno.2009.09.029 ID - Köbel2010 ER - TY - JOUR AU - Timmers, P. J. AU - Zwinderman, A. H. AU - Teodorovic, I. AU - Vergote, I. AU - Trimbos, J. B. PY - 2009 DA - 2009// TI - Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trial JO - Int JGynecol Cancer VL - 19 UR - https://doi.org/10.1111/IGC.0b013e3181991546 DO - 10.1111/IGC.0b013e3181991546 ID - Timmers2009 ER - TY - JOUR AU - Tan, D. S. AU - Kaye, S. PY - 2007 DA - 2007// TI - Ovarian clear cell adenocarcinoma: a continuing enigma JO - J Clin Pathol VL - 60 UR - https://doi.org/10.1136/jcp.2006.040030 DO - 10.1136/jcp.2006.040030 ID - Tan2007 ER - TY - JOUR AU - Tan, D. S. AU - Iravani, M. AU - McCluggage, W. G. AU - Lambros, M. B. AU - Milanezi, F. AU - Mackay, A. AU - Gourley, C. AU - Geyer, F. C. AU - Vatcheva, R. AU - Millar, J. PY - 2011 DA - 2011// TI - Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-1688 DO - 10.1158/1078-0432.CCR-10-1688 ID - Tan2011 ER - TY - JOUR AU - Wu, Z. Z. AU - Lu, H. P. AU - Chao, C. C. PY - 2010 DA - 2010// TI - Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells JO - Biochem Pharmacol VL - 80 UR - https://doi.org/10.1016/j.bcp.2010.03.029 DO - 10.1016/j.bcp.2010.03.029 ID - Wu2010 ER - TY - STD TI - The human protein atlas. http://www.proteinatlas.org/, UR - http://www.proteinatlas.org/ ID - ref13 ER - TY - JOUR AU - Sun, N. K. AU - Huang, S. L. AU - Chien, K. Y. AU - Chao, C. C. K. PY - 2012 DA - 2012// TI - Golgi-SNARE GS28 potentiates cisplatin-induced apoptosis by forming GS28–MDM2–p53 complexes and by preventing the ubiquitination and degradation of p53 JO - Biochem J VL - 444 UR - https://doi.org/10.1042/BJ20112223 DO - 10.1042/BJ20112223 ID - Sun2012 ER - TY - JOUR AU - Ordónez, N. G. PY - 2012 DA - 2012// TI - Napsin a expression in lung and kidney neoplasia: a review and update JO - Adv Anat Pathol VL - 19 UR - https://doi.org/10.1097/PAP.0b013e31823e472e DO - 10.1097/PAP.0b013e31823e472e ID - Ordónez2012 ER - TY - JOUR AU - Wu, Z. -. Z. AU - Sun, N. -. K. AU - Chien, K. -. Y. AU - Chao, C. C. K. PY - 2011 DA - 2011// TI - Silencing of the SNARE protein NAPA sensitizes cancer cells to cisplatin by inducing ERK1/2 signaling, synoviolin ubiquitination and p53 accumulation JO - Biochem Pharmacol VL - 82 UR - https://doi.org/10.1016/j.bcp.2011.08.018 DO - 10.1016/j.bcp.2011.08.018 ID - Wu2011 ER - TY - JOUR AU - Lee, Y. H. AU - Heo, J. H. AU - Kim, T. H. AU - Kang, H. AU - Kim, G. AU - Kim, J. AU - Cho, S. H. AU - An, H. J. PY - 2011 DA - 2011// TI - Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors JO - Int J Gynecol Pathol VL - 30 UR - https://doi.org/10.1097/PGP.0b013e3182063e71 DO - 10.1097/PGP.0b013e3182063e71 ID - Lee2011 ER - TY - JOUR AU - Ordónez, N. G. PY - 2012 DA - 2012// TI - A word of caution regarding napsin a expression in squamous cell carcinomas of the lung JO - Am J Surg Pathol VL - 36 UR - https://doi.org/10.1097/PAS.0b013e31823b13e2 DO - 10.1097/PAS.0b013e31823b13e2 ID - Ordónez2012 ER - TY - STD TI - WMA Declaration of Helsinki - Ethical principles for medical research - involving human subjects. http://www.wma.net/en/30publications/10policies/b3/index.html, UR - http://www.wma.net/en/30publications/10policies/b3/index.html ID - ref19 ER - TY - JOUR AU - Trimbos, J. B. AU - Vergote, I. AU - Bolis, G. AU - Vermorken, J. B. AU - Mangioni, C. AU - Madronal, C. AU - Franchi, M. AU - Tateo, S. AU - Zanetta, G. AU - Scarfone, G. PY - 2003 DA - 2003// TI - Impact of adjuvant chemotherapy and surgical staging in early- stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer–adjuvant ChemoTherapy in ovarian neoplasm trial JO - J Natl Cancer Inst VL - 95 UR - https://doi.org/10.1093/jnci/95.2.113 DO - 10.1093/jnci/95.2.113 ID - Trimbos2003 ER - TY - JOUR AU - Kononen, J. AU - Bubendorf, L. AU - Kallioniemi, A. AU - Bärlund, M. AU - Schraml, P. AU - Leighton, S. AU - Torhorst, J. AU - Mihatsch, M. J. AU - Sauter, G. AU - Kallioniemi, O. P. PY - 1998 DA - 1998// TI - Tissue microarrays for high-throughput molecular profiling of tumor specimens JO - Nat Med VL - 4 UR - https://doi.org/10.1038/nm0798-844 DO - 10.1038/nm0798-844 ID - Kononen1998 ER - TY - JOUR AU - Seidal, T. AU - Balaton, A. J. AU - Battifora, H. PY - 2001 DA - 2001// TI - Interpretation and quantification of immunostains JO - Am J Surg Pathol VL - 25 UR - https://doi.org/10.1097/00000478-200109000-00013 DO - 10.1097/00000478-200109000-00013 ID - Seidal2001 ER - TY - JOUR AU - Köbel, M. AU - Kalloger, S. E. AU - Boyd, N. AU - McKinney, S. AU - Mehl, E. AU - Palmer, C. AU - Leung, S. AU - Bowen, N. J. AU - Ionescu, D. N. AU - Rajput, A. PY - 2008 DA - 2008// TI - Ovarian carcinoma subtypes are different diseases: implications for biomarker studies JO - PLoS Med VL - 5 UR - https://doi.org/10.1371/journal.pmed.0050232 DO - 10.1371/journal.pmed.0050232 ID - Köbel2008 ER - TY - JOUR AU - Skirnisdottir, I. A. AU - Sorbe, B. AU - Lindborg, K. AU - Seidal, T. PY - 2011 DA - 2011// TI - Prognostic impact of p53, p27, and C-MYC on clinicopathological features and outcome in early-stage (FIGO I-II) epithelial ovarian cancer JO - Int J Gynecol Cancer VL - 21 UR - https://doi.org/10.1097/IGC.0b013e31820986e5 DO - 10.1097/IGC.0b013e31820986e5 ID - Skirnisdottir2011 ER - TY - JOUR AU - Skirnisdottir, I. A. AU - Seidal, T. PY - 2013 DA - 2013// TI - Association of p21, p21 p27 and p21 p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer JO - Cancer Genomics Proteomics VL - 10 ID - Skirnisdottir2013 ER - TY - JOUR AU - Kandalaft, P. L. AU - Isacson, C. AU - Gown, A. M. PY - 2012 DA - 2012// TI - The lung-restricted marker napsin a is highly expressed in clear cell carcinomas of the ovary JO - Mod Pathol VL - 25 ID - Kandalaft2012 ER - TY - JOUR AU - Köbel, M. K. S. AU - Huntsman, D. G. AU - Santos, J. AU - Swenerton, K. D. AU - Seidman, J. D. AU - Gilks, C. B. PY - 2009 DA - 2009// TI - A limited panel of immunomarkers Can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary JO - AM J Surg Pathol VL - 33 UR - https://doi.org/10.1097/PAS.0b013e3181788546 DO - 10.1097/PAS.0b013e3181788546 ID - Köbel2009 ER - TY - JOUR AU - Skirnisdottir, I. AU - Seidal, T. AU - Karlsson, M. G. AU - Sorbe, B. PY - 2005 DA - 2005// TI - Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II JO - Int J Oncol VL - 26 ID - Skirnisdottir2005 ER - TY - JOUR AU - Ikeda, K. AU - Sakai, K. Y. R. AU - Hareyama, H. AU - Tsumura, N. AU - Watari, H. AU - Shimizu, M. M. H. AU - Sakuragi, N. PY - 2003 DA - 2003// TI - Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer JO - Int J Gynecol Cancer VL - 13 UR - https://doi.org/10.1111/j.1525-1438.2003.13381.x DO - 10.1111/j.1525-1438.2003.13381.x ID - Ikeda2003 ER - TY - JOUR AU - He, G. AU - Kuang, J. AU - Huang, Z. AU - Koomen, J. AU - Kobayashi, R. AU - Khokhar, A. R. AU - Siddik, Z. H. PY - 2006 DA - 2006// TI - Upregulation of p27 and its inhibition of CDK2/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21 JO - Br J Cancer VL - 95 UR - https://doi.org/10.1038/sj.bjc.6603448 DO - 10.1038/sj.bjc.6603448 ID - He2006 ER - TY - JOUR PY - 2012 DA - 2012// TI - Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies JO - PLoS Med VL - 9 UR - https://doi.org/10.1371/journal.pmed.1001200 DO - 10.1371/journal.pmed.1001200 ID - ref31 ER - TY - JOUR AU - Olsen, C. M. AU - Nagle, C. M. AU - Whiteman, D. C. AU - Ness, R. AU - Pearce, C. L. AU - Pike, M. C. AU - Rossing, M. A. AU - Terry, K. L. AU - Wu, A. H. AU - Risch, H. A. PY - 2013 DA - 2013// TI - Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium JO - Endocr Relat Cancer VL - 20 UR - https://doi.org/10.1530/ERC-12-0395 DO - 10.1530/ERC-12-0395 ID - Olsen2013 ER - TY - JOUR AU - Paulsen, T. AU - Kærn, J. AU - Tropé, C. PY - 2011 DA - 2011// TI - Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery JO - Gynecol Oncol VL - 122 UR - https://doi.org/10.1016/j.ygyno.2011.02.038 DO - 10.1016/j.ygyno.2011.02.038 ID - Paulsen2011 ER - TY - JOUR AU - Vergote, I. AU - De Brabanter, J. AU - Fyles, A. AU - Bertelsen, K. AU - Einhorn, N. AU - Sevelda, P. AU - Gore, M. E. AU - Kærn, J. AU - Verrelst, H. AU - Sjövall, K. PY - 2001 DA - 2001// TI - Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma JO - Lancet VL - 357 UR - https://doi.org/10.1016/S0140-6736(00)03590-X DO - 10.1016/S0140-6736(00)03590-X ID - Vergote2001 ER - TY - JOUR AU - Min, K. W. AU - Park, M. H. AU - Hong, S. R. AU - Lee, H. AU - Kwon, S. Y. AU - Hong, S. H. AU - Joo, H. J. AU - Park, I. A. AU - An, H. J. AU - Suh, K. S. PY - 2013 DA - 2013// TI - Clear cell carcinomas of the ovary: a multi-institutional study of 129 cases in Korea with prognostic significance of Emi1 and Galectin-3 JO - Int J Gynecol Pathol VL - 32 UR - https://doi.org/10.1097/PGP.0b013e31825554e9 DO - 10.1097/PGP.0b013e31825554e9 ID - Min2013 ER - TY - JOUR AU - Wu, Z. -. Z. AU - Chao, C. C. K. PY - 2010 DA - 2010// TI - Knockdown of NAPA using short-hairpin RNA sensitizes cancer cells to cisplatin: implications to overcome chemoresistance JO - Biochem Pharmacol VL - 80 UR - https://doi.org/10.1016/j.bcp.2010.05.026 DO - 10.1016/j.bcp.2010.05.026 ID - Wu2010 ER - TY - JOUR AU - Goldstein, I. AU - Marcel, V. AU - Olivier, M. AU - Oren, M. AU - Rotter, V. AU - Hainaut, P. PY - 2011 DA - 2011// TI - Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies JO - Cancer Gene Ther VL - 18 UR - https://doi.org/10.1038/cgt.2010.63 DO - 10.1038/cgt.2010.63 ID - Goldstein2011 ER - TY - JOUR AU - Zheng, J. X. G. S. AU - Xu, Q. AU - Liu, J. Z. AU - Song, P. PY - 2012 DA - 2012// TI - Inhibition of epithelial-mesenchymal transition in A549 cell by transfected Napsin A JO - Chin Med J VL - 125 ID - Zheng2012 ER - TY - JOUR AU - Muller, P. A. AU - Vousden, K. H. AU - Norman, J. C. PY - 2011 DA - 2011// TI - p53 and its mutants in tumor cell migration and invasion JO - J Cell Biol VL - 192 UR - https://doi.org/10.1083/jcb.201009059 DO - 10.1083/jcb.201009059 ID - Muller2011 ER - TY - JOUR AU - Golubovskaya, V. M. AU - Finch, R. AU - Kweh, F. AU - Massoll, N. A. AU - Campbell-Thompson, M. AU - Wallace, M. R. AU - Cance, W. G. PY - 2008 DA - 2008// TI - p53 regulates FAK expression in human tumor cells JO - Mol Carcinog VL - 47 UR - https://doi.org/10.1002/mc.20395 DO - 10.1002/mc.20395 ID - Golubovskaya2008 ER - TY - JOUR AU - Ueno, T. AU - Elmberger, G. AU - Weaver, T. E. AU - Toi, M. AU - Linder, S. PY - 2008 DA - 2008// TI - The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity JO - Lab Invest VL - 88 UR - https://doi.org/10.1038/labinvest.3700718 DO - 10.1038/labinvest.3700718 ID - Ueno2008 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/13/524/prepub UR - http://www.biomedcentral.com/1471-2407/13/524/prepub ID - ref42 ER -